China Resources Double-Crane Pharmaceutical Co., Ltd. approved the proposal of nominating Zhang Kejian as Independent Director at directorate meeting held on January 22, 2016.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.37 CNY | +2.00% |
|
-0.19% | +14.89% |
14/06 | CR Double-Crane Pharmaceutical Gets Certificate to Market Low-Calcium Dialysis Solution | MT |
27/05 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.89% | 3.01B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- 600062 Stock
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- China Resources Double-Crane Pharmaceutical Co., Ltd. Approves to Nominates Zhang Kejian as Independent Director